Pomalidomide combined with dexamethasone for the treatment of relapsed/refractory multiple myeloma: a systematic review and meta-analysis.

MLA

Luo, Ying, et al. “Pomalidomide Combined with Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis.” Expert Review of Hematology, vol. 17, no. 4/5, Apr. 2024, pp. 127–34. EBSCOhost, https://doi.org/10.1080/17474086.2024.2326219.

APA

Luo, Y., Li, C., Niu, Y., Wu, S., Tian, J., Hu, Z., He, J., Zhang, Z., Liu, H., Li, Y., Wang, T., & Fang, Y. (2024). Pomalidomide combined with dexamethasone for the treatment of relapsed/refractory multiple myeloma: a systematic review and meta-analysis. Expert Review of Hematology, 17(4/5), 127–134. https://doi.org/10.1080/17474086.2024.2326219

Chicago

Luo, Ying, Chen Li, Yuanchen Niu, Shuanzhi Wu, Jingyuan Tian, Zhiqin Hu, Jin He, et al. 2024. “Pomalidomide Combined with Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis.” Expert Review of Hematology 17 (4/5): 127–34. doi:10.1080/17474086.2024.2326219.